Sofwave Medical Ltd
TASE:SOFW
Intrinsic Value
Sofwave Medical Ltd. engages in development, production, marketing, maintenance, and distribution of medical technology for firming and rejuvenating facial and neck skin. [ Read More ]
The intrinsic value of one SOFW stock under the Base Case scenario is 912.7 ILS. Compared to the current market price of 1 778 ILS, Sofwave Medical Ltd is Overvalued by 49%.
Valuation Backtest
Sofwave Medical Ltd
Run backtest to discover the historical profit from buying and selling SOFW stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Sofwave Medical Ltd
Current Assets | 39.8m |
Cash & Short-Term Investments | 24.4m |
Receivables | 10.4m |
Other Current Assets | 4.9m |
Non-Current Assets | 3.8m |
PP&E | 3.5m |
Other Non-Current Assets | 268k |
Current Liabilities | 16.4m |
Accounts Payable | 15.5m |
Other Current Liabilities | 874k |
Non-Current Liabilities | 774k |
Long-Term Debt | 767k |
Other Non-Current Liabilities | 7k |
Earnings Waterfall
Sofwave Medical Ltd
Revenue
|
50.3m
USD
|
Cost of Revenue
|
-12.8m
USD
|
Gross Profit
|
37.5m
USD
|
Operating Expenses
|
-45.5m
USD
|
Operating Income
|
-8m
USD
|
Other Expenses
|
-288k
USD
|
Net Income
|
-8.3m
USD
|
Free Cash Flow Analysis
Sofwave Medical Ltd
SOFW Profitability Score
Profitability Due Diligence
Sofwave Medical Ltd's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
Score
Sofwave Medical Ltd's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
SOFW Solvency Score
Solvency Due Diligence
Sofwave Medical Ltd's solvency score is 80/100. The higher the solvency score, the more solvent the company is.
Score
Sofwave Medical Ltd's solvency score is 80/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SOFW Price Targets Summary
Sofwave Medical Ltd
Shareholder Return
SOFW Price
Sofwave Medical Ltd
Average Annual Return | -31.84% |
Standard Deviation of Annual Returns | 56.29% |
Max Drawdown | -81% |
Market Capitalization | 607.3m ILS |
Shares Outstanding | 341 550 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Sofwave Medical Ltd. engages in development, production, marketing, maintenance, and distribution of medical technology for firming and rejuvenating facial and neck skin. The firm operates itself and through its subsidiaries in the field of development, production, marketing, support and distribution of medical technology Sofwave that delivers Synchronous Ultrasound Parallel Beam SUPERB technology for skin tightening and rejuvenation treatments for the face and neck, which provides a non-invasive solution for skin rejuvenation and tightening, in a safe and clinically effective manner. In addition, the group provides services technical and clinical support for the product it provides. The firm has subsidiary in United States -Sofwave Medical Inc.
Officers
The intrinsic value of one SOFW stock under the Base Case scenario is 912.7 ILS.
Compared to the current market price of 1 778 ILS, Sofwave Medical Ltd is Overvalued by 49%.